In short
- One physician, not a prescription service. Assessment, treatment and follow up stay with the same doctor.
- Months, not one appointment. Reviews are close together while doses change, then settle.
- Medication is a decision, not a given. Suitability is assessed in person and some patients are better served without it.
- A plan for stopping. Weight regain after GLP-1 treatment is discussed at the start, not at the end.
Treatment Overview
What is the Weight Loss Membership?
It is a continuous physician led weight programme rather than a single consultation. You are assessed properly at the start, given a written plan, and then reviewed on a schedule through the months when a plan is most likely to fail without support.
The membership covers the physician side of that work: the first consultation and baseline investigations, the written plan, scheduled reviews, dose adjustment where medication is used, and a defined route to the practice between appointments for side effects or questions that should not wait.
Who runs it?
Dr. Felix runs the programme personally. You see the same physician at every review, which is the point. Weight treatment goes wrong most often when nobody holds the whole picture and each appointment starts again from the beginning.
Who Is a Good Candidate?
- You have lost weight repeatedly and regained it, and you want to understand why rather than try harder at the same approach.
- You are considering prescription only medication and want a physician to decide whether it is appropriate for you.
- You are already on a GLP-1 medicine and want proper supervision, monitoring and a plan for what happens afterwards.
- Your weight is affecting blood pressure, blood sugar, sleep, joints or fertility and you want those treated together rather than separately.
- You want body composition looked after, not just a number on the scale.
- You are looking for rapid cosmetic weight loss without a medical assessment.
- You are pregnant, breastfeeding or planning pregnancy in the near future.
- You have a personal or family history of medullary thyroid carcinoma or MEN2, which rules out this class of medicine.
- You have a current eating disorder, which needs specialist treatment first.
What Happens During the Consultation
-
1
Goals and history
What you want to change and why, what you have already tried, how your appetite behaves through the day, and whether any weight related condition is already diagnosed. Pregnancy plans are part of this conversation, because these medicines are not used in pregnancy.
-
2
Medical review
Examination, weight and waist measurement, blood pressure, and the baseline investigations your case requires, including metabolic, thyroid and liver markers where indicated. Body composition is measured where available, because muscle matters as much as weight.
-
3
Suitability decision
Dr. Felix tells you whether medication is appropriate for you, which one fits your situation, or whether your case is better served another way. If a reversible cause is driving the weight, treating that comes first.
-
4
Your written plan
What is driving your weight, the realistic options, and what each involves in effort, side effects and monitoring. You leave with the plan in writing and the review dates already set.
Program Structure & Follow-Up
How does the membership actually run?
The first months decide whether this works, so contact is closest then.
- Every four to six weeks during titration. A short review before each dose step, checking tolerance, blood pressure and how you are eating.
- Blood tests at the intervals your case needs rather than a fixed panel repeated for everyone.
- Longer reviews once you are stable, usually every three months, looking at body composition, waist, metabolic markers, energy and sleep.
- Access between reviews for side effects or questions that should not wait for the next appointment.
If muscle is being lost alongside fat, the plan changes. If a medicine is not tolerated at a given dose, the dose changes or the approach changes. Nutrition, training and sleep are part of the plan throughout, and protein intake and resistance training matter more on GLP-1 treatment than most patients are told.
Benefits, Limits & Safety
What can this do, and what can go wrong?
Where medication is used, the evidence is good but the numbers are averages and not a promise. In the trial that led to approval of semaglutide for weight management, adults lost on average around 15 percent of body weight over 68 weeks alongside diet and activity change. Individual results vary widely.
- Common side effects. Nausea, vomiting, diarrhoea and constipation, usually in the days after a dose increase, usually settling.
- Less common but important. Gallbladder problems, pancreatitis, dehydration.
- Not used in pregnancy or breastfeeding, or with a personal or family history of medullary thyroid carcinoma or MEN2.
No supply of any specific product is promised and no particular amount of weight loss is guaranteed. What is offered is careful assessment, monitored treatment and honest information. Weight regain after stopping a GLP-1 medicine is common and predictable, and it is discussed openly at the start.
What the evidence shows
Average loss of about 15 percent of body weight over 68 weeks in the semaglutide approval trial, alongside diet and activity change. Tirzepatide trials show higher averages. Individual results vary widely and no number is promised to you.
How you are followed
Reviews every four to six weeks while doses change, then roughly every three months. Weight, waist, body composition, blood pressure and metabolic markers, with repeat blood tests where your case requires them.
When it is not used
Pregnancy, breastfeeding and planned pregnancy. Personal or family history of medullary thyroid carcinoma or MEN2. Active pancreatitis. A current eating disorder needs specialist treatment first.
Cost & Program Investment
The membership covers physician time, reviews and continuity. Investigations are billed at laboratory cost and any medication at pharmacy cost, so you are not paying a markup on either. The exact figure depends on how long you need the programme and what your case involves, and you get it in the consultation before anything starts.
Frequently Asked Questions
Sometimes, but not automatically. Suitability is a physician decision made after examination and, where needed, blood tests. If your results are already available and your case is straightforward, treatment can start at the first visit. If something needs checking first, it gets checked first.
Dose titration alone takes around four months, and most patients stay in active treatment considerably longer than that. Weight treatment is measured in months and years rather than weeks. The membership is built around that reality rather than around a short course.
Weight regain after stopping a GLP-1 medicine is common and expected, which is why the plan for stopping is discussed at the start. Some patients move to a maintenance dose, others step down with a structured nutrition and training plan. Either way it is planned rather than improvised.
No. Medication is billed at pharmacy cost and investigations at laboratory cost. The membership covers the physician work around them: assessment, decisions, monitoring and access. You are told the full picture before you commit.
Evidence
Where this information comes from
Every figure on this page is taken from the sources below. All of them are free to read, so you can check them yourself.
- Obesity and overweight
- Obesity: identification, assessment and management
- Semaglutide for managing overweight and obesity
This page is general medical information and does not replace a personal consultation. Trial results are averages across large groups, not a prediction for any one person.